Large-scale testing (Phase 3)Study completedNCT02504372
What this trial is testing
Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)
Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 1,177